Last reviewed · How we verify

NCT03458065: MYSTIC

T-ICD vs S-ICD Shocks: Myocardial Injuries

Status unknown Last updated 8 March 2018
What this trial tests

trial testing ICD in ICD Shock Myocardial Injuries in 100 participants. Status unknown.

Timeline
1 April 2018
Primary endpoint
1 September 2018
1 March 2019

Quick facts

Lead sponsorMonaldi Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 April 2018
Primary completion1 September 2018
Estimated completion1 March 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Monaldi Hospital

Who can join

18 and older, any sex, with ICD Shock Myocardial Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Implantable cardioverter defibrillator (ICD) shocks are associated with a subsequent increased risk of death, and an elevation of cardiac enzymes has been measured after defibrillation testing (DFT). The aim of our study was to investigate the association between S-ICD vs T-ICD shocks and acute cardiac damage in humans, as evaluated by means of sensitive and highly specific circulating biomarkers

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ICD

Trials testing the same drug.

Other Monaldi Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458065.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing